Literature DB >> 23440979

Fine-needle sampling provides appreciable diagnostic yield in lesions of post kala azar dermal leishmaniasis: analysis of four cases from North Eastern India.

Arghya Bandyopadhyay1, Kaushik Majumdar, Mimi Gangopadhyay, Sankha Koley.   

Abstract

Post-kala-azar dermal leishmaniasis (PKDL) is a sequel of visceral leishmaniasis (VL), usually occurring 6 months to 3 years after VL. Spectrum of cutaneous lesions in PKDL can be hypopigmented macules, nodules, plaques, or erythema. It is usually diagnosed clinically, supplemented by ancillary techniques like skin smear examination, histopathology, polymerase chain reaction, and monoclonal antibody test. Literature on the role of cytology in the diagnosis of PKDL is extremely limited. Here we highlight the appreciable yield of fine-needle sampling in four cases of PKDL, which may be considered as a useful diagnostic aid.
Copyright © 2013 Wiley Periodicals, Inc.

Entities:  

Keywords:  cytology; fine needle sampling (FNS); post-kala-azar dermal leishmaniasis (PKDL)

Mesh:

Year:  2013        PMID: 23440979     DOI: 10.1002/dc.22953

Source DB:  PubMed          Journal:  Diagn Cytopathol        ISSN: 1097-0339            Impact factor:   1.582


  3 in total

1.  A Rare Case of Cutaneous Leishmaniasis Presenting as Rhinophyma.

Authors:  Arghya Bandyopadhyay; Kousik Bose
Journal:  Iran J Pathol       Date:  2015

Review 2.  Post kala-azar dermal leishmaniasis: A threat to elimination program.

Authors:  Mallikarjuna Rao Gedda; Bhawana Singh; Dhiraj Kumar; Abhishek Kumar Singh; Prasoon Madhukar; Shreya Upadhyay; Om Prakash Singh; Shyam Sundar
Journal:  PLoS Negl Trop Dis       Date:  2020-07-02

3.  Evaluation of Real-time PCR for Diagnosis of Post-Kala-azar Dermal Leishmaniasis in Endemic Foci of Bangladesh.

Authors:  Prakash Ghosh; Md Golam Hasnain; Faria Hossain; Md Anik Ashfaq Khan; Rajashree Chowdhury; Khaledul Faisal; Moshtaq Ahmed Mural; James Baker; Rupen Nath; Debashis Ghosh; Shomik Maruf; Mohammad Sohel Shomik; Rashidul Haque; Greg Matlashewski; Shinjiro Hamano; Malcolm S Duthie; Dinesh Mondal
Journal:  Open Forum Infect Dis       Date:  2018-09-15       Impact factor: 3.835

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.